What causes low semen volume?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Low Semen Volume: Causes and Diagnostic Approach

Low semen volume (hypospermia, defined as <1.4-2.0 mL) results from either structural abnormalities of the seminal vesicles/ejaculatory ducts, functional ejaculatory disorders, or hormonal deficiencies affecting accessory gland function. 1, 2

Primary Etiologic Categories

Obstructive/Structural Causes

  • Ejaculatory duct obstruction (EDO) is the most important structural cause, characterized by acidic semen (pH <7.0), low volume (<1.4 mL), and azoospermia or severe oligospermia with very low motility 1, 2
  • Congenital bilateral absence of vas deferens (CBAVD) presents with very low volume and is diagnosed by physical examination showing absent vas deferens bilaterally 1, 2
  • CBAVD is frequently associated with CFTR gene mutations (cystic fibrosis transmembrane conductance regulator), making genetic screening essential 2, 3
  • Seminal vesicle hypoplasia or agenesis reduces the contribution of seminal vesicle fluid, which normally comprises 60-70% of ejaculate volume 4

Functional/Ejaculatory Disorders

  • Partial retrograde ejaculation causes low antegrade volume, diagnosed by post-ejaculatory urinalysis showing sperm in urine 2, 3
  • Post-ejaculatory urinalysis is mandatory when volume is <1 mL (except in patients with bilateral vasal agenesis or hypogonadism) 5, 2
  • Incomplete ejaculation from neurologic dysfunction, medications (alpha-blockers, antipsychotics), or diabetes can reduce volume 4

Hormonal/Endocrine Causes

  • Hypogonadism (low testosterone) impairs prostate and seminal vesicle function, reducing their secretory contribution to semen volume 1, 2
  • Dihydrotestosterone (DHT) specifically regulates semen volume and viscosity through its effects on prostate and seminal vesicle development and function 6
  • Men with 5-alpha-reductase deficiency demonstrate extremely low semen volumes (0.05-1.0 mL) due to rudimentary prostates and small seminal vesicles 6

Medication-Related Causes

  • Finasteride 5 mg/day is associated with reduced semen volume, though data for 1 mg/day are inconclusive 1
  • Exogenous testosterone suppresses gonadotropin secretion and can reduce accessory gland function 7, 2

Collection/Technical Issues

  • Incomplete collection during masturbation is a common artifactual cause that must be excluded by repeat analysis 4, 3
  • Short abstinence intervals (<2 days) result in lower volumes, as repeated ejaculation significantly decreases semen volume 8

Diagnostic Algorithm

Initial Assessment

  • Confirm true hypospermia with at least two semen analyses after 2-3 days of abstinence, as single measurements are unreliable 5, 2
  • Check semen pH immediately: acidic pH (<7.0) with low volume strongly suggests EDO or CBAVD 1, 2
  • Palpate for vas deferens bilaterally: absence indicates CBAVD 2
  • Assess testicular size and consistency: normal-sized testes suggest obstruction, while atrophic testes indicate primary testicular failure 5, 2
  • Perform digital rectal examination to evaluate prostate size and consistency 2

Laboratory Evaluation

  • Measure serum testosterone and FSH: low testosterone with low/normal FSH indicates hypogonadotropic hypogonadism, while elevated FSH (>7.6 IU/L) suggests primary testicular failure 2
  • Post-ejaculatory urinalysis when volume <1 mL to diagnose retrograde ejaculation (except in bilateral vasal agenesis or hypogonadism) 5, 2

Imaging (Selective Use Only)

  • TRUS or pelvic MRI should be reserved for suspected EDO when clinical picture shows: acidic semen, volume <1.4 mL, azoospermia or severe oligospermia with very low motility, normal testosterone, and palpable vas deferens 1, 2
  • Do not perform TRUS or pelvic MRI as part of initial evaluation—this is a common pitfall 1, 2

Genetic Testing When Indicated

  • CFTR gene testing is mandatory for patients with CBAVD before proceeding with assisted reproduction, as female partners require screening 2, 3
  • Karyotype and Y-chromosome microdeletion analysis are required for azoospermia or severe oligospermia (<5 million/mL) 2

Critical Clinical Pearls

  • The combination of low volume, acidic pH, and azoospermia/severe oligospermia with very low motility is pathognomonic for distal genital tract obstruction 1
  • Fructose testing is relatively unreliable and unnecessary when clinical suspicion for EDO or CBAVD is high 1
  • Normal semen volume and pH distinguish non-obstructive azoospermia from obstructive causes 7
  • Age correlates with decreased semen volume even in men with high sperm counts, as older patients with high sperm counts tend to have lower volumes 9

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Low Semen Volume

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Why and how to assess hypospermia?].

Gynecologie, obstetrique & fertilite, 2008

Research

Steps in the investigation and management of low semen volume in the infertile man.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2009

Guideline

Evaluation of Azoospermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Non-Obstructive Azoospermia Causes and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.